{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T13:06:54Z","timestamp":1784380014877,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s40122-023-00513-1","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T11:03:09Z","timestamp":1682679789000},"page":"963-978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Long-Term Safety and Efficacy of Mirogabalin for Central Neuropathic Pain: A Multinational, Phase 3, 52-Week, Open-Label Study in Asia"],"prefix":"10.1007","volume":"12","clinical-trial-number":[{"clinical-trial-number":"nct03901352","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Takahiro","family":"Ushida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Hiasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiro","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Furusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kakehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunika","family":"Kikumori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Kuroha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"issue":"18","key":"513_CR1","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","volume":"70","author":"RD Treede","year":"2008","unstructured":"Treede RD, Jensen TS, Campbell JN, et\u00a0al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70(18):1630\u20135.","journal-title":"Neurology"},{"issue":"3","key":"513_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.pain.2008.04.025","volume":"137","author":"JD Loeser","year":"2008","unstructured":"Loeser JD, Treede RD. The Kyoto protocol of IASP basic pain terminology. Pain. 2008;137(3):473\u20137.","journal-title":"Pain"},{"issue":"9 Suppl","key":"513_CR3","first-page":"S256","volume":"12","author":"B Nicholson","year":"2006","unstructured":"Nicholson B. Differential diagnosis: nociceptive and neuropathic pain. Am J Manag Care. 2006;12(9 Suppl):S256\u201362.","journal-title":"Am J Manag Care"},{"issue":"3","key":"513_CR4","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.mayocp.2016.01.017","volume":"91","author":"JC Watson","year":"2016","unstructured":"Watson JC, Sandroni P. Central neuropathic pain syndromes. Mayo Clin Proc. 2016;91(3):372\u201385.","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"513_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.nrl.2011.08.001","volume":"27","author":"CB Moreno","year":"2012","unstructured":"Moreno CB, Hern\u00e1ndez-Beltr\u00e1n N, Mun\u00e9var D, Guti\u00e9rrez-Alvarez AM. Central neuropathic pain in Parkinson\u2019s disease. Neurologia. 2012;27(8):500\u20133.","journal-title":"Neurologia"},{"issue":"2","key":"513_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/pm\/pnab140","volume":"23","author":"C Canavan","year":"2022","unstructured":"Canavan C, Inoue T, McMahon S, Doody C, Blake C, Fullen BM. The efficacy, adverse events, and withdrawal rates of the pharmacological management of chronic spinal cord injury pain: a systematic review and meta-analysis. Pain Med. 2022;23(2):375\u201395.","journal-title":"Pain Med"},{"issue":"7","key":"513_CR7","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1007\/s12325-020-01388-w","volume":"37","author":"A Liampas","year":"2020","unstructured":"Liampas A, Velidakis N, Georgiou T, et\u00a0al. Prevalence and management challenges in central post-stroke neuropathic pain: a systematic review and meta-analysis. Adv Ther. 2020;37(7):3278\u201391.","journal-title":"Adv Ther"},{"issue":"3","key":"513_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/neurolint12030014","volume":"12","author":"A Edinoff","year":"2020","unstructured":"Edinoff A, Sathivadivel N, McBride T, et\u00a0al. Chronic pain treatment strategies in Parkinson\u2019s disease. Neurol Int. 2020;12(3):61\u201376.","journal-title":"Neurol Int"},{"issue":"3","key":"513_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","volume":"132","author":"RH Dworkin","year":"2007","unstructured":"Dworkin RH, Connor AB, Backonja M, et\u00a0al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132(3):237\u201351.","journal-title":"Pain"},{"issue":"1","key":"513_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3344\/kjp.2020.33.1.3","volume":"33","author":"M Davari","year":"2020","unstructured":"Davari M, Amani B, Amani B, Khanijahani A, Akbarzadeh A, Shabestan R. Pregabalin and gabapentin in neuropathic pain management after spinal cord injury: a systematic review and meta-analysis. Korean J Pain. 2020;33(1):3\u201312.","journal-title":"Korean J Pain"},{"issue":"3","key":"513_CR11","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4103\/neuroindia.NI_45_16","volume":"65","author":"J Kalita","year":"2017","unstructured":"Kalita J, Chandra S, Misra UK. Pregabalin and lamotrigine in central poststroke pain: a pilot study. Neurol India. 2017;65(3):506\u201311.","journal-title":"Neurol India"},{"key":"513_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2147\/JPR.S63028","volume":"7","author":"K Onouchi","year":"2014","unstructured":"Onouchi K, Koga H, Yokoyama K, Yoshiyama T. An open-label, long-term study examining the safety and tolerability of pregabalin in Japanese patients with central neuropathic pain. J Pain Res. 2014;7:439\u201347.","journal-title":"J Pain Res"},{"issue":"5","key":"513_CR13","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.pain.2010.12.023","volume":"152","author":"JS Kim","year":"2011","unstructured":"Kim JS, Bashford G, Murphy TK, Martin A, Dror V, Cheung R. Safety and efficacy of pregabalin in patients with central post-stroke pain. Pain. 2011;152(5):1018\u201323.","journal-title":"Pain"},{"issue":"Suppl","key":"513_CR14","first-page":"95","volume":"14","author":"O Hesami","year":"2015","unstructured":"Hesami O, Gharagozli K, Beladimoghadam N, Assarzadegan F, Mansouri B, Sistanizad M. The efficacy of gabapentin in patients with central poststroke pain. Iran J Pharm Res. 2015;14(Suppl):95\u2013101.","journal-title":"Iran J Pharm Res"},{"issue":"1","key":"513_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/WNF.0000000000000122","volume":"39","author":"K Abe","year":"2016","unstructured":"Abe K, Chiba Y, Katsuse O, Hirayasu Y. A case of Parkinson disease with both visual hallucination and pain improved by gabapentin. Clin Neuropharmacol. 2016;39(1):55\u20136.","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"513_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s40265-019-01070-8","volume":"79","author":"ED Deeks","year":"2019","unstructured":"Deeks ED. Mirogabalin: first global approval. Drugs. 2019;79(4):463\u20138.","journal-title":"Drugs"},{"issue":"2","key":"513_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3390\/ph14020112","volume":"14","author":"R Zaj\u0105czkowska","year":"2021","unstructured":"Zaj\u0105czkowska R, Mika J, Leppert W, Kocot-K\u0119pska M, Malec-Milewska M, Wordliczek J. Mirogabalin: a novel selective ligand for the \u03b12\u03b4 calcium channel subunit. Pharmaceuticals (Basel). 2021;14(2):112.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"11","key":"513_CR18","doi-asserted-by":"publisher","first-page":"e1193","DOI":"10.1212\/WNL.0000000000201709","volume":"100","author":"T Ushida","year":"2023","unstructured":"Ushida T, Katayama Y, Hiasa Y, et\u00a0al. Mirogabalin for central neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled, phase 3 study in Asia. Neurology. 2023;100(11):e1193\u2013206.","journal-title":"Neurology"},{"key":"513_CR19","unstructured":"Japanese package insert of mirogabalin. 2022. https:\/\/pins.japic.or.jp\/pdf\/newPINS\/00070625.pdf. (In Japanese). Accessed 21 Dec 2022."},{"issue":"2","key":"513_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","volume":"30","author":"R Melzack","year":"1987","unstructured":"Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987;30(2):191\u20137.","journal-title":"Pain"},{"issue":"Suppl 1","key":"513_CR21","doi-asserted-by":"publisher","first-page":"S98","DOI":"10.1002\/mds.22716","volume":"25","author":"B Ford","year":"2010","unstructured":"Ford B. Pain in Parkinson\u2019s disease. Mov Disord. 2010;25(Suppl 1):S98-103.","journal-title":"Mov Disord"},{"key":"513_CR22","unstructured":"European Medicines Agency. ICH Topic E1. Population exposure: the extent of population exposure to assess clinical safety. 1995. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-e-1-population-exposure-extent-population-exposure-assess-clinical-safety-step-5_en.pdf. Accessed 07 June 2022."},{"issue":"3","key":"513_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/jdi.13178","volume":"11","author":"M Baba","year":"2020","unstructured":"Baba M, Natsui N, Kuroha M. Long-term safety and efficacy of mirogabalin in Asian patients with diabetic peripheral neuropathic pain. J Diabetes Investig. 2020;11(3):693\u20138.","journal-title":"J Diabetes Investig"},{"issue":"10","key":"513_CR24","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1080\/03007995.2019.1629757","volume":"35","author":"LM Arnold","year":"2019","unstructured":"Arnold LM, Whitaker S, Hsu C, Jacobs D, Merante D. Efficacy and safety of mirogabalin for the treatment of fibromyalgia: results from three 13-week randomized, double-blind, placebo- and active-controlled, parallel-group studies and a 52-week open-label extension study. Curr Med Res Opin. 2019;35(10):1825\u201335.","journal-title":"Curr Med Res Opin"},{"issue":"36","key":"513_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021976","volume":"99","author":"J Kato","year":"2020","unstructured":"Kato J, Matsui N, Kakehi Y, Murayama E, Ohwada S. Long-term safety and efficacy of mirogabalin in Asian patients with postherpetic neuralgia: results from an open-label extension of a multicenter randomized, double-blind, placebo-controlled trial. Medicine (Baltimore). 2020;99(36): e21976.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"513_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1124\/jpet.117.247551","volume":"365","author":"Y Domon","year":"2018","unstructured":"Domon Y, Arakawa N, Inoue T, et\u00a0al. Binding characteristics and analgesic effects of mirogabalin, a novel ligand for the \u03b12\u03b4 subunit of voltage-gated calcium channels. J Pharmacol Exp Ther. 2018;365(3):573\u201382.","journal-title":"J Pharmacol Exp Ther"},{"issue":"17","key":"513_CR27","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1080\/14656566.2021.1958780","volume":"22","author":"J Kato","year":"2021","unstructured":"Kato J, Inoue T, Yokoyama M, Kuroha M. A review of a new voltage-gated Ca2+ channel \u03b12\u03b4 ligand, mirogabalin, for the treatment of peripheral neuropathic pain. Expert Opin Pharmacother. 2021;22(17):2311\u201322.","journal-title":"Expert Opin Pharmacother"},{"key":"513_CR28","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2147\/JMDH.S105857","volume":"9","author":"O Skogar","year":"2016","unstructured":"Skogar O, Lokk J. Pain management in patients with Parkinson\u2019s disease: challenges and solutions. J Multidiscip Healthc. 2016;9:469\u201379.","journal-title":"J Multidiscip Healthc"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-023-00513-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-023-00513-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-023-00513-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T07:14:30Z","timestamp":1687590870000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-023-00513-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1007\/s40122-023-00513-1","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"21 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}